These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32880720)

  • 1. Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis.
    Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; van der Mei I
    J Neurol; 2021 Feb; 268(2):602-612. PubMed ID: 32880720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis.
    Chen J; Taylor B; Winzenberg T; Palmer AJ; Kirk-Brown A; van Dijk P; Simpson S; Blizzard L; van der Mei I
    Mult Scler; 2020 Oct; 26(12):1550-1559. PubMed ID: 33063620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms.
    Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; van der Mei I
    J Neurol; 2021 Feb; 268(2):559-568. PubMed ID: 32876720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
    Tettey P; Siejka D; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; van der Mei I
    Neuroepidemiology; 2016; 46(2):106-13. PubMed ID: 26784322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of comorbidities with sleep quality among Australians with multiple sclerosis: Insights from the Australian Multiple Sclerosis Longitudinal Study.
    Dagnew B; Laslett LL; Honan CA; Blizzard L; Winzenberg T; Taylor BV; van der Mei I
    Mult Scler; 2024 Jun; 30(7):877-887. PubMed ID: 38738517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.
    Salter A; Lancia S; Kowalec K; Fitzgerald KC; Marrie RA
    Neurology; 2024 Mar; 102(5):e209135. PubMed ID: 38350062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.
    Maric GD; Pekmezovic TD; Mesaros ST; Tamas OS; Ivanovic JB; Martinovic VN; Andabaka MM; Jovanovic AL; Veselinovic ND; Kisic-Tepavcevic DB; Drulovic JS
    Neurol Sci; 2021 May; 42(5):1887-1893. PubMed ID: 32964347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.
    Ciampi E; Uribe-San-Martin R; Soler B; Molnar K; Reyes D; Keller K; Carcamo C
    Mult Scler Relat Disord; 2020 Nov; 46():102565. PubMed ID: 33039942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data.
    Campbell JA; Simpson S; Ahmad H; Taylor BV; van der Mei I; Palmer AJ
    Mult Scler; 2020 Oct; 26(11):1315-1328. PubMed ID: 31347952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis.
    Rotstein D; Maxwell C; Tu K; Gatley J; Pequeno P; Kopp A; Marrie RA
    Mult Scler; 2021 Oct; 27(12):1902-1913. PubMed ID: 34328821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
    Thormann A; Magyari M; Koch-Henriksen N; Laursen B; Sørensen PS
    J Neurol; 2016 Dec; 263(12):2484-2493. PubMed ID: 27699465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
    Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; Ahmad H; Hussain MA; van der Mei I
    J Neurol; 2021 Feb; 268(2):569-581. PubMed ID: 32880072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular comorbidities in the onset and progression of multiple sclerosis.
    Tettey P; Simpson S; Taylor BV; van der Mei IA
    J Neurol Sci; 2014 Dec; 347(1-2):23-33. PubMed ID: 25454639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia.
    Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
    Mult Scler; 2012 Sep; 18(9):1310-9. PubMed ID: 22328682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland.
    Kapica-Topczewska K; Tarasiuk J; Chorąży M; Czarnowska A; Brola W; Szczepański M; Kochanowicz J; Kułakowska A
    Mult Scler Relat Disord; 2020 Jun; 41():102051. PubMed ID: 32197130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.
    Marrie RA; Rudick R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Neurology; 2010 Mar; 74(13):1041-7. PubMed ID: 20350978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between comorbidity and clinical characteristics of MS.
    Marrie RA; Horwitz RI; Cutter G; Tyry T; Vollmer T
    Acta Neurol Scand; 2011 Aug; 124(2):135-41. PubMed ID: 20880264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study.
    Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
    Neuroepidemiology; 2013; 40(2):85-92. PubMed ID: 23095571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal Study.
    Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; Hussain MA; van der Mei I
    Eur J Neurol; 2021 Jul; 28(7):2269-2279. PubMed ID: 33931923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity is associated with pain-related activity limitations in multiple sclerosis.
    Fiest KM; Fisk JD; Patten SB; Tremlett H; Wolfson C; Warren S; McKay KA; Berrigan L; Marrie RA;
    Mult Scler Relat Disord; 2015 Sep; 4(5):470-476. PubMed ID: 26346797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.